We review the role of noradrenaline in cardiogenic shock. We describe our experience with the same after percutaneous coronary intervention, mostly primary angioplasty. The side effects of noradrenaline, the results of the SOAP 2 and the IABP Shock trial are also discussed. Noradrenaline is surprisingly a useful drug. So we want to share our experience with it.